Trial NCT01353482

View at ClinicalTrials.gov 
Org. Study IDs: UCL/08/0359
Secondary IDs: 2009-013638-26

Last trial update was posted on 2012-03-22

MeSH Interventions

Pemetrexed Vorinostat

MeSH Conditions

Mesothelioma Mesothelioma, Malignant

Other Conditions

Malignant Pleural Mesothelioma

Stopping Reasons

UCL CTC were informed by Merck Sharp & Dohme on 22.08.11 that support for the trial had been withdrawn in light of results from another trial with trial drug.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID